Hetero Labs Gets CDSCO Panel Nod To study Semaglutide Injection for Type 2 Diabetes Mellitus Dr. Divya Colin10 March 2025 6:00 PM ISTNew Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Choice of Beverage May Help Reduce Mortality and CVD in Adults with Type 2 DM Dr Monish Raut2 May 2023 9:30 AM ISTAccording to the results of a recent prospective cohort research, adults with type 2 diabetes (T2D) who drank more sugar-sweetened beverages (SSB) had...
High HbA1c levels may increase dementia risk in type 2 diabetes patients: JAMA Dr. Mahalakshmi Sivashankaran19 April 2023 11:00 AM ISTAustralia: Dementia is a growing concern, especially in older populations. New research published in JAMA: Neurology suggests that adults with type...
Gestational Glucose Intolerance Puts Young Women at High Risk for Type 2 Diabetes: The Lancet Dr. Mahalakshmi Sivashankaran8 April 2023 10:00 AM ISTIsrael: A new study has revealed that women who experience glucose intolerance during pregnancy, even if it does not meet the criteria for ...
Menstrual history may hold the key to women's heart health: BMC Medicine Dr. Mahalakshmi Sivashankaran3 April 2023 1:52 PM ISTUK: A new study published in BMC Medicine has found that menstrual cycle characteristics could be an important factor in predicting cardiovascular...
Low-Carb, High-Quality Diet Linked to Lower Mortality Rates in People with Type 2 Diabetes, Study Finds Dr. Mahalakshmi Sivashankaran31 March 2023 11:15 AM ISTUSA: New research published in the Diabetes Care Journal suggests that low-carbohydrate diets (LCD) could lower mortality risk in individuals with...
SGLT2-Is and MRAs combo associated with lower albuminuria in patients with type 2 DM Dr. Shravani Dali20 Jan 2023 8:00 PM ISTCombination therapy with SGLT2-Is and MRAs is associated with lower albuminuria in patients with type 2 DM compared to monotherapy with SGLT2-Is or...
Finerenone improves cardiorenal outcomes among patients of diabetes with CKD: The FIDELITY Trial Dr. Kamal Kant Kohli21 Oct 2022 10:30 AM ISTU.S.A.: A trial that was recently published in the Journal of the American College of Cardiology reported that finerenone, a selective, nonsteroidal...
Nasal septal abscess risk higher in type 2 DM patients, Finds study Dr. Nandita Mohan31 July 2021 9:00 AM ISTUncontrolled diabetes mellitus is considered a risk factor for nasal septal abscess (NSA) development in patients without trauma. However, T2DM is...
